epoprostenol

epoprostenol
Trade Name Flolan
Orphan Indication Secondary pulmonary hypertension
USA Market Approval USA
USA Designation Date 1999-03-22 00:00:00
Sponsor GlaxoSmithKline;2301 Renaissance Blvd, P. O. Box 61540;King of Prussia, Pennsylvania, 19406